R3 Vascular Appoints Josh Smale as its Vice President of Global Clinical and Scientific Affairs
July 09, 2024 14:25 ET
|
R3 Vascular
R3 Vascular Inc. is pleased to announce the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.
Peripheral Arterial Disease (PAD) Therapeutics Global Strategic Research Report 2024
March 01, 2024 06:43 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Peripheral Arterial Disease (PAD) Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...